PortfoliosLab logoPortfoliosLab logo
BIOY vs. FTQI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BIOY vs. FTQI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GraniteShares YieldBOOST Biotech ETF (BIOY) and First Trust Nasdaq BuyWrite Income ETF (FTQI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


BIOY

1D
-3.35%
1M
-2.48%
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*

FTQI

1D
-0.18%
1M
0.69%
6M
11.24%
YTD
12.14%
1Y
25.21%
3Y*
16.53%
5Y*
11.93%
10Y*
8.12%
ALL TIME*
7.03%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOY vs. FTQI - Yearly Performance Comparison


Correlation

The correlation between BIOY and FTQI is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since May 5, 2026

0.19

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIOY vs. FTQI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


FTQI
FTQI Risk / Return Rank: 9191
Overall Rank
FTQI Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
FTQI Sortino Ratio Rank: 8989
Sortino Ratio Rank
FTQI Omega Ratio Rank: 8989
Omega Ratio Rank
FTQI Calmar Ratio Rank: 9090
Calmar Ratio Rank
FTQI Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOY vs. FTQI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and First Trust Nasdaq BuyWrite Income ETF (FTQI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BIOYFTQIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.43

Calmar ratioReturn relative to maximum drawdown

4.06

Martin ratioReturn relative to average drawdown

19.14

BIOY vs. FTQI - Sharpe Ratio Comparison


Loading charts...

Drawdowns

BIOY vs. FTQI - Drawdown Comparison

The maximum BIOY drawdown since its inception was -6.64%, smaller than the maximum FTQI drawdown of -19.42%. Use the drawdown chart below to compare losses from any high point for BIOY and FTQI.


Loading charts...

Drawdown Indicators


BIOYFTQIDifference

Max Drawdown

Largest peak-to-trough decline

-6.64%

-19.42%

+12.78%

Max Drawdown (1Y)

Largest decline over 1 year

-6.24%

Max Drawdown (3Y)

Largest decline over 3 years

-19.42%

Max Drawdown (5Y)

Largest decline over 5 years

-19.42%

Max Drawdown (10Y)

Largest decline over 10 years

-19.42%

Current Drawdown

Current decline from peak

-6.64%

-1.39%

-5.25%

Average Drawdown

Average peak-to-trough decline

-2.16%

-3.72%

+1.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.32%

Volatility

BIOY vs. FTQI - Volatility Comparison


Loading charts...

Volatility by Period


BIOYFTQIDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.90%

Volatility (6M)

Calculated over the trailing 6-month period

8.83%

Volatility (1Y)

Calculated over the trailing 1-year period

18.55%

10.90%

+7.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.55%

14.80%

+3.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.55%

12.94%

+5.61%

BIOY vs. FTQI - Expense Ratio Comparison

BIOY has a 1.07% expense ratio, which is higher than FTQI's 0.75% expense ratio.


Dividends

BIOY vs. FTQI - Dividend Comparison

BIOY's dividend yield for the trailing twelve months is around 13.82%, more than FTQI's 10.98% yield.


PositionTTM20252024202320222021202020192018201720162015
BIOY
GraniteShares YieldBOOST Biotech ETF
13.82%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FTQI
First Trust Nasdaq BuyWrite Income ETF
10.98%11.46%11.66%11.49%9.85%3.05%3.27%2.95%3.27%2.74%3.02%3.54%

Frequently Asked Questions


BIOY and FTQI have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, FTQI is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

FTQI is cheaper with a 0.75% expense ratio, compared with 1.07% for BIOY.

BIOY has the higher dividend yield at 13.82%, compared with 10.98% for FTQI.

BIOY is categorized as Derivative Income, while FTQI is Nasdaq-100. They also come from different issuers: GraniteShares and First Trust. Their fees differ too: 1.07% for BIOY and 0.75% for FTQI.

Portfolio Optimizer

Find the right allocation for BIOY and FTQI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer